Injured By Xarelto? Get The Justice And Compensation You Deserve.

Xarelto (rivaroxaban) Lawsuit Claims 2017 – Do You Qualify?

Last Updated: April 20, 2017 – You may still be entitled to compensation if you have suffered from severe side effects after taking certain blood-thinning medications.

Xarelto (rivaroxaban) is a blood thinner that has been used by more than 9,000,000 people around the world who have suffered from ailments and conditions like blood clots in their lungs, veins, or legs. Some folks have even had to take it after getting their knee(s) or hip(s) replaced. The good news is that Xarelto has helped protect millions of people from potentially deadly blood clots, by preventing them from forming in the first place. But now, the drug makers Johnson & Johnson and Bayer have been hit with numerous lawsuits related to this medication from people claiming that Xarelto caused them to bleed internally, sent them to the hospital, and even faced brushes with death.

One of the first people to file suit was Virginia Stunteneck of Kentucky, who landed in the hospital with really bad stomach bleeding. According to Stunteneck, this occurred after she had take rivaroxaban, and the drug’s manufacturers knew that their medication came with serious side effects. The problem, according to the lawyers, is that the drug giants decided to remain silent and continued selling it, even in the face of mounting evidence that its use came with potentially deadly consequences. Because of this, people who may have been injured or faced serious side effects from Xarelto could be entitled to compensation. You can find out if you qualify by calling the number listed on this page, or simply clicking this link to connected now:

The precedent for such a suit may have been set in motion after another drug manufacturer, Boehringer Ingelheim, was forced to shell out more than $600 million to settle thousands of suits brought against them for internal bleeding allegedly caused by their drug, Pradaxa.

Both Pradaxa and rivaroxaban were created as alternatives to another blood thinning medication, warfarin. Warfarin has been in use for nearly half a century, and has been used to successfully treat blood clots during this time. Warfarin can also carry the risk of uncontrolled bleeding, but unlike the two newer meds on the market, it comes with an antidote that can put a stop to the bleeding. Without such an antidote, patients confronted with uncontrollable bleeding can face death in the worst of cases.

rivaroxaban-litigationEven though the drug has been on the market since 2011, many people are just now finding out about the risks, so it’s reasonable to assume that there are many more lawsuits on the horizon, and if the $650 million Pradaxa settlement is any indicator, Bayer and Johnson & Johnson could potentially be on the hook for some big payouts down the road. However, even with mass litigation looming, experts are predicting that Xarelto could continue maintaining its status as a cash cow. In its very first year on the market Xarelto brought in more than $430 million in Europe and another $240 million in U.S. sales. With that in mind, and sales continuing to grow, projections have the drug raking in more than $3.5 billion annually in the next several years. So even if they do end up shelling out hundreds of millions of dollars, it may just be another drop in the bucket when all is said and done.

A Strike Against Xarelto?

The floodgates opened against rivaroxaban after the FDA denied its approval to treat patients suffering from acute coronary syndrome (ACS), but as of the summer of 2014 only about 10 or so lawsuits had been filed in the United States. As part of their ruling, the FDA eliminated the possibility of Xarelto being used for heart attack and stroke prevention, citing a lack of data needed to support such a decision. The number of lawsuits is expected to grow however largely because as more and more people have used Xarelto, there has also been an increase in side-effects reported, according to FiercePharma. In fact, a little more than halfway through 2013 nearly 1,000 German patients had reported some form of side effect after taking the drug, and there were even 72 deaths. Because of this some doctors have become hesitant about prescribing the drug, if there are other options that they can try first. Even with all of this though, Xarelto saw a steady sales increase of nearly 250% in the first part of 2013, so any of the negative publicity hasn’t appeared to have a huge impact on the drug’s steady rise in popularity.

With all of that being said, there are still plenty of people who have been using Xarelto to successfully treat a variety of symptoms and ailments, without any major side effects. If you feel that it could be an option for you then it is always a good idea to check with your physician to see if it might be an option. If you have already taken Xarelto and have experienced an adverse reaction, then you may want to consult an attorney to see what your options may be going forward.

>>CLICK HERE to Start Qualification Process

More Resources:

Anticoagulant Central 


No Responses to “Xarelto Lawsuit and Litigation”

No comments yet.
error: Content is protected !!